GM1 gangliosidosis

Views & Analysis

Rare disease families need to stand up and be counted if they want things to change said mum and advocate Christine Waggoner.

News

Jazz Pharma has dipped its toe into the M&A water again, agreeing to buy rare epilepsy drug developer Actio Bio for $820m upfront.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.